- • In partnership with LloydsPharmacy, 2San launches eight new affordable self-diagnostic tests
- The new tests open the door to self-testing for LloydsPharmacy customers
- The listing is a major milestone for 2San as its first nationwide listing
2San, a global supplier of high-quality innovative healthcare products and solutions, has secured its first nationwide listing with leading UK pharmacy, LloydsPharmacy. This February, eight new ‘over the counter’ rapid self-diagnostic kits are launching on LloydsPharmacy website with nationwide availability. The kits will put the products directly into the consumers’ hands, democratising healthcare, breaking down barriers and eliminating pressures on healthcare services and allow people to make informed decisions about their own health.
The partnership with LloydsPharmacy is part of 2San’s vision for Better Care. Better Life. Since self-diagnostic tests became commonplace during the peak of the COVID19 pandemic, the idea of taking an initial test at home to self-diagnose has become increasingly acceptable and appealing to consumers with specific health demands. In fact, 87% of consumers that used COVID-19 lateral flow tests trusted the quality and outcome of test results1, paving the way for 82.5% of the group surveyed welcoming the idea of being able to effectively manage aspects of their own health & wellness from home using self-tests before needing to approach the doctor2.
Recent data from a study undertaken by IPSOS on behalf of 2San found that 91% of consumers were happy with the process of self-diagnostic testing,3 and when asked what is most appealing about using self-diagnostics, the top three priorities were speed of results (29%), ability to take control of your own health (24%), and reducing the strain on NHS services (21%)4. All showcasing the rise in consumer demand for this type of product.